Roivant Sciences Ltd.
ROIV
$10.66
$0.242.30%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 163.06% | -102.97% | -- |
| Total Depreciation and Amortization | -- | -- | -6.55% | 107.42% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -1,087.09% | 100.40% | -- |
| Change in Net Operating Assets | -- | -- | -607.68% | -24.72% | -- |
| Cash from Operations | -- | -- | -77.79% | 48.46% | -7.14% |
| Capital Expenditure | -- | -- | -176.50% | 1.69% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.02% | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -113.93% | -99.87% | 14,456.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 76.14% | -0.04% | -- |
| Issuance of Common Stock | -- | -- | -37.87% | -58.84% | -- |
| Repurchase of Common Stock | -- | -- | -2,210.26% | -763.69% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | -- | -- | -1,924.94% | -113.79% | 13.84% |
| Foreign Exchange rate Adjustments | -- | -- | -220.47% | -128.11% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -534.89% | -102.57% | 19,987.64% |
